P66-Shc as predictive marker in cancer treatment

Details for Australian Patent Application No. 2006315651 (hide)

Owner Roger Williams Hospital

Inventors Frackelton Jr., A. Raymond

Agent Davies Collison Cave

Pub. Number AU-A-2006315651

PCT Pub. Number WO2007/058965

Priority 60/735,729 11.11.05 US; 60/843,788 12.09.06 US

Filing date 10 November 2006

Wipo publication date 24 May 2007

International Classifications

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

29 May 2008 PCT application entered the National Phase

  PCT publication WO2007/058965 Priority application(s): WO2007/058965

5 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006315655-Brazing material with continuous length layer of elastomer containing a flux

2006315638-Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements